2 The technology

2 The technology

2.1 SeHCAT is a radiopharmaceutical that is licensed for use in measuring bile acid pool loss and investigating bile acid malabsorption. It can also be used in the assessment of ileal function, to investigate inflammatory bowel disease (IBD) and chronic diarrhoea, and to study enterohepatic circulation.

  • National Institute for Health and Care Excellence (NICE)